首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
【2h】

A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory

机译:Lynch综合征的分子诊断学综述:病理实验室的核心作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Lynch syndrome (LS) is caused by mutations in mismatch repair genes and is characterized by a high cumulative risk for the development of mainly colorectal carcinoma and endometrial carcinoma. Early detection of LS is important since surveillance can reduce morbidity and mortality. However, the diagnosis of LS is complicated by the absence of a pre-morbid phenotype and germline mutation analysis is expensive and time consuming. Therefore it is standard practice to precede germline mutation analysis by a molecular diagnostic work-up of tumours, guided by clinical and pathological criteria, to select patients for germline mutation analysis. In this review we address these molecular analyses, the central role for the pathologist in the selection of patients for germline diagnostics of LS, as well as the molecular basis of LS.
机译:林奇综合症(LS)是由失配修复基因的突变引起的,其特征是主要发生大肠癌和子宫内膜癌的累积风险很高。 LS的早期发现很重要,因为监视可以降低发病率和死亡率。然而,由于缺乏病前表型,LS的诊断变得复杂,种系突变分析既昂贵又费时。因此,在临床和病理学标准的指导下,通过对肿瘤的分子诊断检查来进行种系突变分析之前,选择患者进行种系突变分析是一种标准实践。在这篇综述中,我们着眼于这些分子分析,这是病理学家在选择LS种系诊断患者的过程中的核心作用,以及LS的分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号